• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 11, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Making this Parkinson’s drug is just turtles all the way down (video)

Bioengineer by Bioengineer
June 17, 2024
in Chemistry
Reading Time: 2 mins read
0
Making this Parkinson's drug is just turtles all the way down (video)
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

WASHINGTON, June 17, 2024 — L-DOPA is the best drug we have for Parkinson’s disease, but its molecular mirror image, D-DOPA, causes dangerous side effects. Making L-DOPA without also making D-DOPA is surprisingly hard and requires a specific kind of molecule to pull off. But that specific molecule must be made from a different and equally specific molecule. In this video, our host, George Zaidan, explains how one of the winners of the 2001 Nobel Prize in Chemistry pulled it off, and why “chiral synthesis,” as it’s called, is really just turtles all the way down. https://youtu.be/_cb09XB07LQ?si=BuMEI5fOuHmuQlkZ

Making this Parkinson's drug is just turtles all the way down (video)

Credit: The American Chemical Society

WASHINGTON, June 17, 2024 — L-DOPA is the best drug we have for Parkinson’s disease, but its molecular mirror image, D-DOPA, causes dangerous side effects. Making L-DOPA without also making D-DOPA is surprisingly hard and requires a specific kind of molecule to pull off. But that specific molecule must be made from a different and equally specific molecule. In this video, our host, George Zaidan, explains how one of the winners of the 2001 Nobel Prize in Chemistry pulled it off, and why “chiral synthesis,” as it’s called, is really just turtles all the way down. https://youtu.be/_cb09XB07LQ?si=BuMEI5fOuHmuQlkZ

Reactions is a video series produced by the American Chemical Society and PBS Digital Studios. Subscribe to Reactions at http://bit.ly/ACSReactions and follow us on X, formerly Twitter @ACSReactions.

The American Chemical Society (ACS) is a nonprofit organization chartered by the U.S. Congress. ACS’ mission is to advance the broader chemistry enterprise and its practitioners for the benefit of Earth and all its people. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, eBooks and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact [email protected].

Follow us: Twitter | Facebook | Instagram

 



Share12Tweet7Share2ShareShareShare1

Related Posts

Random-Event Clocks Offer New Window into the Universe’s Quantum Nature

Random-Event Clocks Offer New Window into the Universe’s Quantum Nature

September 11, 2025
Portable Light-Based Brain Monitor Demonstrates Potential for Advancing Dementia Diagnosis

Portable Light-Based Brain Monitor Demonstrates Potential for Advancing Dementia Diagnosis

September 11, 2025

Scientists reinvigorate pinhole camera technology for advanced next-generation infrared imaging

September 11, 2025

BeAble Capital Invests in UJI Spin-Off Molecular Sustainable Solutions to Advance Disinfection and Sterilization Technologies

September 11, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    63 shares
    Share 25 Tweet 16
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Complete Chloroplast Genome of Cyathea delgadii Revealed

Smart ROS Nanoplatform Boosts Targeted Cancer Therapy

Creating AI Companions for Caregiver Role Transitions

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.